Home / Contract Awards / Navy Selects Six Firms for C2 Tech Supply Contracts

Navy Selects Six Firms for C2 Tech Supply Contracts

Six companies have won potential 10-year, cost-plus-fixed-fee contracts to provide command-and-control platforms and related technology for the U.S. Navy.

The Department of Defense said Tuesday the Naval Information Warfare Center Pacific received 14 bids for the multiple-award, indefinite-delivery/indefinite-quantity contracts, each containing a two-year base term and four two-year options.

The contractors will support the service’s net-centric military operations and offer C2 capabilities across systems engineering, science and technology research, quality assurance, architecture, configuration management, design, testing, development and integration areas.

Work will occur in San Diego through May 6, 2021 under each contract’s base period and could extend through May 6, 2029 if all options are exercised.

The awardees and their respective contract details are listed below:

  • Advanced Sciences and Technologies: base value of $68.1M and ceiling value of $93M
  • Data Intelligence: base value of $48.1M and ceiling value of $93M
  • Forward Slope: base value of $76.9M and ceiling value of $93M
  • G2 Software Systems: base value of $83.5M and ceiling value of $93M
  • Geocent: base value of $83.3M and ceiling value of $93M
  • Solute: base value of $55.9M and ceiling value of $93M

The Navy will obligate $10K in working capital funds for fiscal 2019 at the time of award.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.